Although some previous studies indicated that CRC may be resilient to TGF-β-induced EMT and that mesenchymal genes are mainly expressed by stromal cells but not by cancer cells11,14, another study reported activation of the TGF-β pathway in a cancer-cell intrinsic CRC subtype15. The gene discussed is TGFB1; the disease is colorectal carcinoma.